0.0700
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
685.2690
951.6620
1,820.5410
1,739.7020
661.8820
Cost of Revenue
223.5400
552.1250
881.0520
1,249.2410
516.6440
Gross Profit
461.7290
399.5370
939.4890
490.4610
145.2380
Operating Expense
3,565.2540
3,756.8430
7,710.1140
9,666.1770
5,742.0080
Operating Income
-3,103.5250
-3,357.3060
-6,770.6250
-9,175.7160
-5,596.7700
Net Non Operating Interest Income Expense
-39.7160
-39.7160
-33.3160
--
-168.6210
Other Income Expense
-876.5920
685.4530
3,129.9070
2,423.7440
-4,570.1530
Pretax Income
-4,019.8330
-2,711.5690
-3,674.0340
-6,751.9720
-10,335.5440
Net Income Common Stockholders
-4,019.8330
-2,711.5690
-3,674.0340
-6,751.9720
-10,335.5440
Diluted NI Available to Com Stockholders
-4,019.8330
-2,711.5690
-3,674.0340
-6,751.9720
-10,335.5440
Basic EPS
-0.02
-0.03
-0.09
-0.13
-0.23
Diluted EPS
-0.02
-0.03
-0.09
-0.13
-0.23
Basic Average Shares
142,792.0880
104,415.6480
76,630.4400
50,722.0110
45,356.2190
Diluted Average Shares
142,792.0880
104,415.6480
76,630.4400
50,722.0110
45,356.2190
Total Operating Income as Reported
-3,095.3150
-3,349.0960
-6,793.6690
-9,143.8860
-6,988.1170
Total Expenses
3,788.7940
4,308.9680
8,591.1660
10,915.4180
6,258.6520
Net Income from Continuing & Discontinued Operation
-4,019.8330
-2,711.5690
-3,674.0340
-6,751.9720
-10,335.5440
Normalized Income
-3,143.2410
-3,397.0220
-6,803.9410
-9,175.7160
-5,765.3910
Interest Expense
--
--
--
--
168.6210
Net Interest Income
-39.7160
-39.7160
-33.3160
--
-168.6210
EBIT
-4,665.5700
-3,357.3060
-6,770.6250
-6,751.9720
-10,166.9230
EBITDA
-4,453.8220
-3,144.8080
-6,558.1270
-6,539.8510
-10,032.2990
Reconciled Cost of Revenue
223.5400
552.1250
881.0520
1,249.2410
516.6440
Reconciled Depreciation
211.7480
212.4980
212.4980
212.1210
134.6240
Net Income from Continuing Operation Net Minority Interest
-4,019.8330
-2,711.5690
-3,674.0340
-6,751.9720
-10,335.5440
Total Unusual Items Excluding Goodwill
-876.5920
685.4530
3,129.9070
2,423.7440
-4,570.1530
Total Unusual Items
-876.5920
685.4530
3,129.9070
2,423.7440
-4,570.1530
Normalized EBITDA
-3,577.2300
-3,830.2610
-9,688.0340
-8,963.5950
-5,462.1460
12/31/2020 - 1/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade